Study #2021-1073
EMB01X201; Phase Ib/II, Open-Label Study of EMB-01 in Patients with Advanced/Metastatic Gastrointestinal Cancers
MD Anderson Study Status
Not Accepting
Treatment Agent
EMB-01
Description
This study is to evaluate the safety and antitumor activity of EMB-01 in advanced/metastatic gastrointestinal cancers, including gastric cancer, hepatocellular cancer, cholangiocarcinoma and colorectal cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Neoplasms, Neoplasm Metastasis, Metastatic Gastrointestinal Carcinoid Tumor
Study phase:
Physician name:
Christine Parseghian
Department:
Gastrointestinal Medical Oncology
For general questions about clinical trials:
1-844-929-4217
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.